Tonghuashun (300033) Financial Research Center, May 7, an investor asked Jincheng Pharmaceutical (300233)(300233) what products are synthetic biology currently generating revenue for your company, and what products will be put into production in the future?

The company replied, Hello, investors! The company has been deeply engaged in the field of synthetic biology for many years, has built an internationally leading synthetic biology industrialization platform, and has successfully implemented biosynthetic products such as glutathione, adenosylmethionine, astaxanthin, and PQQ, as well as 4-AA, nicotine, etc. Enzyme catalyzed products. Establishment of authoritative teams in the company and the fieldplayjeopardyWith close industry-university-research cooperation and platform co-construction, a complete synthetic biology industry chain has been formed from upstream research and development, pilot scale expansion to industrialization. Currently, there are many products under research, and the company will actively promote the progress of product research and development to achieve it as soon as possible. Industrialization. Thank you for your attention to the company!